In pre-clinical models, BPC 157 has been observed to: Upregulate vascular endothelial growth factor (VEGF) , promoting new blood vessel formation in damaged tissue Modulate nitric oxide (NO) synthesis pathways, influencing vascular tone and healing cascades Interact with the growth hormone receptor system , potentially amplifying downstream tissue repair signaling Demonstrate cytoprotective effects along the gastrointestinal tract its native home territory as a gastric peptide Exhibit apparent neuroprotective properties in rodent models of CNS injury BPC 157 stability in gastric acid unusual for peptides has made it a focus of GI mucosal repair research
2023;79:104055 Mahani M, Taheri M, Divsar F, Khakbaz F, Nomani A, Ju H
When brain chemistry is dysregulated, talk therapy has limited reach
Adverse Effects They arent trivial, well beyond injection site swelling and redness
Glutamine is not typically associated with weight gain